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ABSTRACT
Background: Supracervical robotic-assisted laparoscopic
sacrocolpopexy (SRALS) is a new surgical treatment for
pelvic organ prolapse that secures the cervical remnant to
the sacral promontory. We present our initial experience
with SRALS in the same setting as supracervical robotic-
assisted hysterectomy (SRAH).
Methods: Women with vaginal vault prolapse and signif-
icant apical defects as defined by a Baden-Walker score of
3 who had not undergone hysterectomy were offered
SRALS in combination with SRAH. A chart review was
performed to analyze operative and perioperative data.
Outcome data also included patients who underwent ro-
botic-assisted laparoscopic sacrocolpopexy (RALS) with-
out any other procedure.
Results: Thirty-three patients underwent RALS, including
12 patients who underwent SRALS. All SRALS were per-
formed following SRAH in the same setting. The mean
follow-up for the RALS and SRALS patients was 38.4
months and 20.7 months, respectively. One patient in the
RALS group had an apical recurrence. There were no
recurrences in the SRALS group.
Conclusions: SRALS is effective for repair of apical vag-
inal defects in patients with significant pelvic organ pro-
lapse who have not undergone previous hysterectomy.
Complications are few and recurrences rare in short- and
medium-term follow-up. Greater follow-up and numbers
are needed to further establish the role of this procedure.
Key Words: Robot, Sacrocolpopexy, Prolapse, Supracer-
vical hysterectomy.
INTRODUCTION
Hysterectomy is one of the most common surgical proce-
dures performed in the United States with approximately
600 000 cases performed annually.1 Although this proce-
dure is most commonly performed via an open abdominal
or vaginal approach, laparoscopic hysterectomy has been
increasing in popularity since it was first described.1,2 In
keeping with technological advances, robotic-assisted
hysterectomy and its results have since been reported as
an effective means to overcoming the technical limitations
of laparoscopic total hysterectomy (TLH).3,4
The majority of hysterectomies are performed for benign
uterine pathology.5,6 Because of the benign nature of the
disease, supracervical or subtotal hysterectomy through a
laparoscopic or open approach has been introduced. The
supracervical hysterectomy removes only the uterus and
leaves the cervix with the intention of preserving sexual,
urinary, and bowel function. However, a Cochrane re-
view7 and professional committee opinion8 on supracer-
vical hysterectomy do not advocate this procedure over
total hysterectomy based on the lack of data suggesting
preserved sexual and urinary function along with the risk
of postoperative symptoms related to the remaining cer-
vical stump, such as vaginal bleeding and pelvic pain.
While these are reported potential postoperative results,9
long-term outcomes of laparoscopic supracervical hyster-
ectomy (LSH) have demonstrated high patient satisfaction
rates, because the cervical symptoms are temporary and
of minimal severity when these symptoms occur.10 Sup-
porters of LSH also contend that this procedure is not as
difficult to perform as TLH is and has a lower risk of injury
to adjacent organs, such as the ureters or bladder.2,11,12
One of the benign gynecological conditions for which a
hysterectomy may be undertaken is pelvic organ prolapse
(POP).13 Pelvic organ prolapse is a common female prob-
lem with 30% of women 50 years to 89 years of age
presenting with POP-related symptoms, and 11% of
women undergoing a corrective procedure for POP by
age 80.14,15 These POP repair procedures are most com-
monly vaginal sacrospinous ligament fixation and abdom-
inal sacrocolpopexy. Although abdominal sacrocol-
popexy has longer operative and recovery times,
recurrence rates are lower than that of the sacrospinous
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SCIENTIFIC PAPERligament fixation procedure.16 Recovery time has since
decreased with the introduction of the laparoscopic sacral
colpopexy by Nezhat17 in 1994 while retaining high suc-
cess rates.18 The introduction of robotic-assisted laparo-
scopic sacrocolpopexy has added the laparoscopic advan-
tages of shorter operative and recovery times by negating
the technical difficulties of conventional laparoscopy
while maintaining high success rates.19–21
Supracervical robotic-assisted laparoscopic sacrocol-
popexy (SRALS) is a new minimally invasive surgical
option for apical pelvic organ prolapse that can be
performed in the same setting as supracervical robotic-
assisted hysterectomy (SRAH). We present our prelim-
inary results and technique of SRALS performed imme-
diately following SRAH and in conjunction with
updated outcomes of patients who underwent robotic-
assisted laparoscopic sacrocolpopexy (RALS) without a
concurrent procedure.
PATIENTS AND METHODS
The charts of 33 consecutive patients who underwent
robotic-assisted POP repair from July 2005 through June
2009 were reviewed. Supracervical robotic-assisted lapa-
roscopic sacrocolpopexy in the same setting as SRAH was
performed in 12 of these patients while the other 21
patients underwent RALS after previously having under-
gone total hysterectomy. All patients were preoperatively
evaluated with a history and physical examination. All
patients had a minimum apical vaginal vault prolapse of
Baden-Walker grade 3. Following SRAH, which was of-
fered to patients for treatment of their high grade POP,
SRALS was performed during the same operating room
session. Existing cystoceles or rectoceles were not re-
paired in this setting.
Procedure
The patient is placed in the modified lithotomy position.
The shoulders are padded and the patient is secured with
padding and 3-inch silk tape placed in an X pattern across
the anterior chest. Security of positioning is assured when
there is no movement of the patient placed in a steep
Trendelenburg position.
Laparoscopic instrument ports are then placed in the ab-
domen. Initially, a Veress needle is placed immediately
supraumbilically, which is subsequently replaced with a
12-mm camera following intraperitoneal insufflation. Un-
der direct vision, two 8-mm, robotic instrument ports are
placed laterally and inferiorly to the camera port. These 2
ports are placed approximately one handbreadth away
from the camera port to prevent collision between robotic
arms. A third 8-mm robotic instrument port is placed
inferiorly and far to the left to be used by the fourth arm
for retraction, if needed. A 12-mm port is placed inferiorly
and on the far right near the iliac crest to be used by the
assistant surgeon.
The robot is docked between the patient’s legs, although
side-docking is possible and preferred with the new ver-
sion of the robotic platform. Supracervical robotic-assisted
hysterectomy is performed, during which the bladder is
dissected away from the uterus and vaginal cuff by first
incising the overlying peritoneum. Dissection is then per-
formed inferiorly and laterally through this peritoneal in-
cision to separate the uterus from the bladder. Once the
outline of the uterocervical junction is visualized, the
uterus is removed via electrocautery. The cervical stump is
left in place. The uterosacral ligaments are also spared to
maximize pelvic organ support. The proximal end of the
cervical stump is oversewn in a simple interrupted fashion
with 0 polyglactin suture. The excised uterus is then
placed in the right pericolic gutter to be morcellated fol-
lowing completion of SRALS.
The sacral promontory is then identified posterior to the
sigmoid colon, and the overlying tissue is dissected away
and multiple 2-0 nonabsorbable monofilament sutures are
preplaced in the periosteum (Figure 1) for eventual fix-
ation of the graft. Approximately 4cm of the sacral prom-
ontory is exposed in a longitudinal direction. A polypro-
pylene Y-graft (AMS, Minneapolis, MN) is placed through
the assistant port and trimmed to the appropriate tension-
Figure 1. Dissection of and 2-0 permanent monofilament suture
placement into sacral promontory.
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determined by placing the cervical stump in an anatomi-
cally appropriate position by using a hand-held vaginal
retractor and trimming the graft to the length that will
maintain this position. One arm of the Y-graft is fixed to
the posterior aspect of the cervical stump in a simple
interrupted fashion with approximately six to eight 2-0
polyglactin sutures as shown in Figure 2. The other Y-
graft arm is fixed to the anterior aspect of the cervical
stump in a similar fashion. Exposure for this portion of the
procedure is aided by a vaginal retractor. The tail of the
Y-graft is then fixed to the sacral promontory with 2-0
nonabsorbable monofilament suture in a simple inter-
rupted fashion. The graft is retroperitonealized by closing
the retroperitoneum over the graft with 3-0 polyglactin
suture in a running fashion.
RESULTS
A total of 33 patients had a robotic-assisted sacrocol-
popexy for surgical treatment of Baden-Walker grade 3 or
greater apical vaginal vault prolapse. Twenty-one of these
patients had previously undergone total hysterectomy,
and therefore, were treated with RALS. The other 12 pa-
tients were treated with SRAH and SRALS in the same
setting for correction of their high grade POP. The ages,
body weight, operative time, estimated blood loss, preop-
erative-to-postoperative hemoglobin change, length of
follow-up, and complications are shown in Table 1.
The average operative time for the RALS procedure was
194 minutes. The average operating room time for the
combined SRAH and SRALS procedures was 284 minutes.
Operating room times included induction of anesthesia,
robot docking, and awakening from anesthesia. The ad-
ditional time for the combination procedure is likely an
overestimation from including anesthesia time and robot
docking, because specific procedure times were not uni-
formly available for review. This extra time also can be
attributed both to the order of the procedures, because the
SRAH required initial dissection, and to supracervical ex-
cision of the uterus prior to undertaking dissection for and
completion of the supracervical sacrocolpopexy. This ad-
ditional procedure also resulted in a mean estimated
blood loss (EBL) of only 68mL more than the mean 50mL Figure 2. Fixation of Y-graft arm to posterior aspect of cervical
stump with 2-0 polyglactin suture.
Table 1.
Roobotic-assisted Laparoscopic Sacrocolpopexy (RALS) & Supracervical Robotic-assisted Laparoscopic Sacrocolpopexy
(SRALS) Results
RALS SRALS with SRAH
Number of patients 21 12
Mean age (range) 65 years (43–86) 59 (39–66)
Mean body weight (range) 72.2 kg (53–112) 68.4 kg (53–104)
Mean operative time (range) 194 minutes (137–280) 284 minutes (236–346)
Mean estimated blood loss (range) 50 mL (25–150) 108 mL (50–225)
Mean hemoglobin change (range) 0.4 g/dL (0.3—2.3) 1.0 g/dL (0.1—2.7)
Mean follow up (range) 38.4 months (11–50) 20.7 months (3–30)
Complications
a 11
Apical prolapse recurrences 1 0
aOne patient for both RALS & SRALS developed small bowel obstruction secondary to entrapment of a loop of bowel beneath the mesh
graft in the first postoperative week. Neither patient required bowel resection. There were no mesh erosions.
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likely due to the extra dissection and organ excision hav-
ing taken place in the SRAH portion, and was not associ-
ated with any intraoperative or postoperative complica-
tions or blood transfusions. There were no procedures
performed to correct cystocele or rectocele at the time of
RALS or SRALS. All but 2 of the RALS patients were dis-
charged on postoperative day 1. These 2 patients with
conservatively managed known third-degree heart block
and postoperative fever, respectively, were discharged on
postoperative day 2. All SRALS patients were discharged
to home on postoperative day 1.
There has been only one apical recurrence after RALS,
which occurred at 7 months and was corrected with sub-
sequent sacrospinous ligament fixation. This apical recur-
rence was due to early separation of the Y-graft from the
sacral promontory when absorbable suture was used early
in the RALS series. Permanent suture has since been used
for all other sacral promontory fixations. There has been
one complication secondary to RALS. One patient devel-
oped a small bowel obstruction on postoperative day 5
secondary to a loop of small bowel trapped posterior to
the Y-graft. Small bowel resection was not necessary.
There has been one similar complication in the SRALS
series. On postoperative day 6, one patient developed a
small bowel obstruction secondary to a loop of small
bowel trapped behind the Y-graft. On exploratory lapa-
rotomy, the loop of small bowel was viable and did not
require resection. How small bowel migrated posterior to
the graft is unknown, because this Y-graft, like all of the
others, was retroperitonealized. All grafts continue to be
retroperitonealized. There have been no mesh erosions
with RALS or SRALS. There have been no complaints of
adverse changes to urinary or sexual function with RALS
or SRALS.
DISCUSSION
Abdominal sacrocolpopexy for repair of apical vaginal
vault prolapse is an improvement on previous methods,
such as anterior abdominal fixation.22,23 Although abdom-
inal sacrocolpopexy for POP repair was initially accom-
panied by longer operative times, higher morbidity, lon-
ger hospital stays, and longer recovery times than vaginal
repair was, recurrence rates and resultant dyspareunia
have been significantly lower.16,24,25 However, technolog-
ical advancements have enabled the development of lapa-
roscopic sacrocolpopexy,17 which has decreased the pro-
cedure’s morbidity and hospital stay,18,26 but requires
significant practice for proficiency. Subsequently, sacro-
colpopexy was introduced using the robotic-assisted lapa-
roscopic approach, which eased the technical burden.
Robotic sacrocolpopexy also maintained low morbidity
and recovery times of laparoscopy while retaining the
high success rates of the original procedure.19–21 In these
robotic-assisted laparoscopic sacrocolpopexy outcome re-
ports, the patients had previously undergone hysterec-
tomy, which also has been reported using robotics.3,4
In addition to augmenting the current literature on RALS,
this is also the first series on SRALS in combination with
SRAH. Our data update previously reported outcomes for
RALS21 and are consistent with other reported outcomes
on RALS in posthysterectomy patients.19,20 Operative time,
blood loss, morbidity, hospital stay, complication rate,
and recurrence rates were low, even with significant fol-
low-up periods. This series’ data also demonstrate that
SRALS in the same setting as SRAH for the correction of
apical vaginal vault prolapse is effective. Morbidity, hos-
pital stay, and complication rates are low, and there have
been no recurrences or mesh erosions with SRALS. Oper-
ating room time and blood loss were increased compared
with those in RALS. Mean overall operating room time was
approximately 90 minutes longer for SRALS with SRAH,
and mean EBL was only 68mL more than RALS. Like RALS,
SRALS does not correct other anatomic defects, such as
cystocele or rectocele. However, with high success rates,
follow-up periods up to 30 months, SRALS with SRAH may
be an effective treatment option for high-grade apical
vaginal vault prolapse. These results are especially signif-
icant for patients with apical POP who are already under-
going supracervical hysterectomy for benign uterine pa-
thology. Considering the results of both RALS and SRALS,
we also reason that SRALS alone would be effective in
patients who have previously undergone supracervical
hysterectomy.
While the interpretation of these data is limited by its
retrospective collection and small number of patients, this
description and the results of SRALS with SRAH can be
important for future treatment options of apical vaginal
vault prolapse. Despite the relative increase in operative
time and blood loss, there have not been any complica-
tions directly related to this combination procedure. This
is important because approximately 3% of women, which
is likely an underestimation, in the United States have
symptomatic POP with rates increasing with age.27 While
approximately 11% of these women will have surgical
correction by age 80,15 over half of this population will
have surgery before age 60 years.28 A notable portion of
these surgeries will be hysterectomies, as 15% of hyster-
ectomies in the United States are performed for POP13
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Thus, a high surgical treatment rate at a relatively young
age is an important aspect of POP and emphasizes the
need to maximize success rates to minimize future proce-
dures for recurrence. Pelvic organ prolapse repair at the
time of hysterectomy has been attempted with uterosacral
ligament fixation.29 However, symptomatic recurrence at
rates of 12.5% and 4.6% were noted for laparoscopically
and vaginally approached uterosacral ligament fixation,
respectively. A Cochrane review has also shown that an
abdominal sacrocolpopexy is better than a vaginal sacro-
spinous colpopexy regarding recurrence rate and postop-
erative symptoms.16 The high surgical treatment rate for
POP makes SRALS in the same setting as SRAH a good
option for treatment. These 2 procedures use the same
approach and are known to be effective for apical vaginal
vault prolapse correction. The marginal expected increases
in operative time and blood loss along with long-term fol-
low-up without apical prolapse recurrence also serves the
purpose of using a combined procedure approach to max-
imize success rates and potentially minimize secondary pro-
cedures with the patient under anesthesia. Moreover, mini-
mal postoperative symptoms regarding sexual and urinary
function are another benefit that may be considered. Should
patients have benign uterine pathology along with apical
vaginal vault prolapse, this combination procedure of SRAH
with SRALS could be offered as effective concomitant treat-
ment.
CONCLUSION
SRALS in combination with SRAH may be a reasonable op-
tion to repair apical vaginal vault defects in patients with
high-grade pelvic organ prolapse and benign uterine pathol-
ogy requiring treatment, and merits further consideration
and formal evaluation. Hospital stay was routinely limited to
1 day. Complications for both RALS and SRALS are minimal.
As previously noted for RALS, cystocele and rectocele are not
treated with SRALS. Short- and medium-term follow-up dem-
onstrate good success rates for both RALS and SRALS with
SRAH, but larger numbers of patients are needed to firmly
establish the role of these procedures in the treatment of
apical vaginal vault prolapse.
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